Test Price
2,800 AED✅ Home Collection Available
CHD8 Gene Autism Susceptibility Type 18 Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
Your clinically accredited CHD8 genetic analysis delivers 99.9% diagnostic sensitivity with ISO-certified laboratory processing. Benefit from premium hospital-grade VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM, with secure courier transport and a mandatory post-test telehealth consultation with a DHA-licensed Consultant Medical Geneticist. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731. This test adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection and Federal Law No. 2 of 2019 concerning health information technology, ensuring complete family-centered neurodevelopmental care.
Test Overview & Methodology
This targeted next-generation sequencing (NGS) test analyzes the entire CHD8 gene to detect pathogenic variants linked to autism spectrum disorder type 18, enabling early intervention and personalized care planning. The assay employs full-gene interrogation with proprietary bioinformatics pipelines validated for clinical diagnostic use.
| Parameter | Our Test | Closest Alternative |
|---|---|---|
| Precision | Full CHD8 gene interrogation | Broad panel, limited coverage |
| Methodology | NGS + proprietary bioinformatics | Exome or genome sequencing |
| Turnaround | 3–4 weeks | 6–8 weeks |
| Clinical Guidance | DHA-licensed post-test consult with Consultant Medical Geneticist | Often limited to raw data only |
Physician Insight & Safety Protocols
A Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics – DHA Registration ID: 9294403
A child’s neurodevelopmental journey requires careful clinical correlation. Genetic findings must always be interpreted alongside comprehensive behavioral assessments to avoid undue anxiety. I strongly advise discussing results with your treating neurologist or medical geneticist before implementing any lifestyle or therapeutic changes.
Advisory Notice – Medication and Clinical Management
Never discontinue, adjust, or initiate any prescribed medication or therapy based solely on genetic test results without direct supervision from your managing physician. Genetic predisposition information is one component of a holistic diagnostic assessment.
Exclusion Criteria & Emergency Red Flags
- Minors without explicit legal guardian informed consent (ref. Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Individuals in acute psychiatric crisis or unstable mental state preventing safe receipt of genetic results.
- Patients with active untreated medical emergencies requiring stabilization prior to elective genetic testing.
ER Red Flags: Sudden worsening of repetitive behaviors, self-harm, severe regression, or loss of previously acquired skills – seek immediate emergency medical attention.
Patient FAQ & Clinical Guidance
1. What is the CHD8 gene autism susceptibility test?
The CHD8 gene autism susceptibility NGS test identifies pathogenic DNA variants in the CHD8 gene associated with autism spectrum disorder type 18. This analysis supports clinical diagnosis, early intervention planning, and informed family counseling by detecting heritable mutations that influence neurodevelopmental trajectories.
2. Who should consider this test?
Individuals with a confirmed autism diagnosis, unexplained developmental delay, intellectual disability, or a documented family history suggestive of CHD8-related neurodevelopmental conditions are ideal candidates for this sequencing panel. A referral from a neurologist, psychiatrist, or geneticist is recommended prior to testing.
3. How long do results take and how are they delivered?
Results are typically reported within 3 to 4 weeks from sample receipt. They are delivered via a secure encrypted digital portal, and every report is accompanied by a mandatory post-test genetics counseling session with a DHA-licensed Consultant Medical Geneticist to ensure proper interpretation and clinical integration.
UAE Regulatory & Data Privacy Adherence
🏅 ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – Corporate Lab: DNA Labs UAE, DHA Facility License: 1143.
✅ VIP Mobile Phlebotomy & Cold-Chain Home Collection – Available daily 8 AM to 11 PM. WhatsApp Support: +971 54 548 8731.
🔒 Data Protection Compliance: All processing adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | CHD8 Gene Autism Susceptibility Type 18 Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or saliva (Oragene DNA collection kit) |
| Methodology Used | Next-Generation Sequencing (NGS) – full CHD8 gene coverage with proprietary bioinformatics analysis |
| ICD-10-CM Code | F84.0 |
| LOINC Code | 82320-4 |
| DHA Facility License & Lab Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians